iridium has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, L; Li, C; Liu, R; Lv, Y; Su, Z; Zhan, Z | 1 |
| Chen, BB; Chen, JX; He, SF; Liao, JX; Pan, NL; Song, XD; Sun, J; Wang, GH | 1 |
2 other study(ies) available for iridium and Experimental Hepatoma
| Article | Year |
|---|---|
Multimodal Imaging Iridium(III) Complex for Hypochlorous Acid in Living Systems.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Coordination Complexes; Fluorescent Dyes; Humans; Hypochlorous Acid; Iridium; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Structure; Optical Imaging | 2020 |
Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Guanidine; Hep G2 Cells; Humans; Iridium; Liver Neoplasms, Experimental; Mice; Mitochondria; Molecular Structure; Optical Imaging; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Structure-Activity Relationship | 2019 |